L-type Ca2+ channel blockers inhibit the window contraction of mouse aorta segments with high affinity

European Journal of Pharmacology

Volumn 738, Issue , 2014, Pages 170-178

  Michiels, Cédéric F ^a   Van Hove, Cor E ^a   Martinet, Wim ^a   De Meyer, Guido R Y ^a   Fransen, Paul ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Calcium channel blocker; Contraction; Depolarization; L type calcium channel; Vascular reactivity

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; DILTIAZEM; NIFEDIPINE; VERAPAMIL;

ANIMAL TISSUE; AORTA; ARTICLE; BINDING AFFINITY; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFICACY; MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; ANIMAL; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; VASOCONSTRICTION; VASODILATATION;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; AORTA; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; MEMBRANE POTENTIALS; MICE; VASOCONSTRICTION; VASODILATION;

EID: 84902237632     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.05.036     Document Type: Article

References (33)

1. 2+ influx in rat femoral arterial smooth muscle Eur. J. Pharmacol. 366 1999 61 71 (Pubitemid 29076722)
2. B.P. Bean, M. Sturek, A. Puga, and K. Hermsmeyer Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs Circ. Res. 59 1986 229 235 (Pubitemid 16017878)
3. W.A. Catterall Voltage-gated calcium channels Cold Spring Harb. Perspect. Biol. 3 2011 1 23
4. C.A. Cobine, B.P. Callaghan, and K.D. Keef Role of L-type calcium channels and PKC in active tone development in rabbit coronary artery Am. J. Physiol. Heart Circ. Physiol. 292 2007 H3079 H3088
5. B.K. Fleischmann, R.K. Murray, and M.I. Kotlikoff Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells Proc. Natl. Acad. Sci. U. S. A 91 1994 11914 11918 (Pubitemid 24368574)
6. P. Fransen, C.E. Van Hove, J. van Langen, D.M. Schrijvers, W. Martinet, G.R. De Meyer, and H. Bult Contribution of transient and sustained calcium influx, and sensitization to depolarization-induced contractions of the intact mouse aorta BMC Physiol. 12 2012 9
7. 2+ channel voltage window in mouse aortic segments is modulated by nitric oxide H. Sugi, Current Basic and Pathological Approaches to the Function of Muscle Cells and Tissues - From Molecules to Humans 2012 Intech Rijeka, Croatia 69 92 www.intech.com
8. 2+ channels activation and contraction elicited by myricetin on vascular smooth muscles Naunyn Schmiedebergs Arch. Pharmacol. 368 2003 470 478 (Pubitemid 38041310)
9. T. Godfraind Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis Philos. Trans. R. Soc. Lond. B Biol. Sci. 360 2005 2259 2272 (Pubitemid 46682145)
10. T. Godfraind, M. Finet, J.S. Lima, and R.C. Miller Contractile activity of human coronary arteries and human myocardium in vitro and their sensitivity to calcium entry blockade by nifedipine J. Pharmacol. Exp. Ther. 230 1984 514 518 (Pubitemid 14061636)
11. G.H. Hockerman, B.Z. Peterson, B.D. Johnson, and W.A. Catterall Molecular determinants of drug binding and action on L-type calcium channels Annu. Rev. Pharmacol. Toxicol. 37 1997 361 396 (Pubitemid 27238881)
12. C. Koumaras, M. Tzimou, E. Stavrinou, T. Griva, T.D. Gossios, N. Katsiki, V.G. Athyros, D.P. Mikhailidis, and A. Karagiannis Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics Am. J. Cardiovasc. Drugs 12 2012 143 156
13. F. Kum, and J. Karalliedde Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness Integr. Blood Press Control 3 2010 63 71
14. L. Lacinova Voltage-dependent calcium channels Gen. Physiol. Biophys. 24 Suppl. 1 2005 S1 S78
15. G. Leonetti, C. Cuspidi, L. Sampieri, L. Terzoli, and A. Zanchetti Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects J. Cardiovasc. Pharmacol. 4 Suppl. 3 1982 S319 S324
16. 2+ channels in cardiac and smooth muscles Cardiovasc. Res. 68 2005 197 203 (Pubitemid 41428416)
17. v1.2 calcium channel splice variant underlies hyperpolarized window current and enhanced state-dependent inhibition by nifedipine J. Biol. Chem. 282 2007 35133 35142 (Pubitemid 350232457)
18. I.S. Mackenzie, C.M. McEniery, Z. Dhakam, M.J. Brown, J.R. Cockcroft, and I.B. Wilkinson Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension Hypertension 54 2009 409 413
19. v1.2 for blood pressure regulation EMBO J. 22 2003 6027 6034 (Pubitemid 37463246)
20. N. Morel, and T. Godfraind Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle J. Pharmacol. Exp. Ther. 243 1987 711 715 (Pubitemid 18011561)
21. N. Morel, and T. Godfraind Selective interaction of the calcium antagonist amlodipine with calcium channels in arteries of spontaneously hypertensive rats J. Cardiovasc. Pharmacol. 24 1994 524 533 (Pubitemid 24303151)
22. 2+ channels: is membrane depolarization the signal? Circ. Res. 94 2004 e97 104
23. 2+ channels in mesenteric and skeletal arteries of SHR Hypertension 40 2002 214 219 (Pubitemid 34840101)
24. S.W. Rhee, J.R. Stimers, W. Wang, and L. Pang Vascular smooth muscle-specific knockdown of the noncardiac form of the L-type calcium channel by microRNA-based short hairpin RNA as a potential antihypertensive therapy J. Pharmacol. Exp. Ther. 329 2009 775 782
25. S. Sonkusare, P.T. Palade, J.D. Marsh, S. Telemaque, A. Pesic, and N.J. Rusch Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications Vascul. Pharmacol. 44 2006 131 142 (Pubitemid 43185988)
26. 2+ channels Trends Pharmacol. Sci. 19 1998 108 115 (Pubitemid 28197812)
27. 2+ channels in smooth muscle cells from pig proximal urethra Br. J. Pharmacol. 144 2005 919 925 (Pubitemid 40593017)
28. C.E. Van Hove, C. Van der Donckt, A.G. Herman, H. Bult, and P. Fransen Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells Br. J. Pharmacol. 158 2009 920 930
29. J. Williams, J. Bogwu, and A. Oyekan The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice J. Hypertens. 24 2006 1429 1436 (Pubitemid 43948344)
30. A. Zahradnikova, I. Minarovic, and I. Zahradnik Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists J. Pharmacol. Exp. Ther. 322 2007 638 645 (Pubitemid 47105781)
31. 2+ Am. J. Physiol. Heart Circ. Physiol. 292 2007 H415 H425
32. 2+ channel Chin Med. J. 121 2008 1513 1517
33. M.A. Zulliger, A. Rachev, and N. Stergiopulos A constitutive formulation of arterial mechanics including vascular smooth muscle tone Am. J. Physiol. Heart Circ. Physiol. 287 2004 H1335 H1343